280 related articles for article (PubMed ID: 22618245)
1. Targeting NOX enzymes in pulmonary fibrosis.
Hecker L; Cheng J; Thannickal VJ
Cell Mol Life Sci; 2012 Jul; 69(14):2365-71. PubMed ID: 22618245
[TBL] [Abstract][Full Text] [Related]
2. NADPH oxidases: Pathophysiology and therapeutic potential in age-associated pulmonary fibrosis.
Kato K; Hecker L
Redox Biol; 2020 Jun; 33():101541. PubMed ID: 32360174
[TBL] [Abstract][Full Text] [Related]
3. The NOX toolbox: validating the role of NADPH oxidases in physiology and disease.
Altenhöfer S; Kleikers PW; Radermacher KA; Scheurer P; Rob Hermans JJ; Schiffers P; Ho H; Wingler K; Schmidt HH
Cell Mol Life Sci; 2012 Jul; 69(14):2327-43. PubMed ID: 22648375
[TBL] [Abstract][Full Text] [Related]
4. Redox Imbalance in Idiopathic Pulmonary Fibrosis: A Role for Oxidant Cross-Talk Between NADPH Oxidase Enzymes and Mitochondria.
Veith C; Boots AW; Idris M; van Schooten FJ; van der Vliet A
Antioxid Redox Signal; 2019 Nov; 31(14):1092-1115. PubMed ID: 30793932
[No Abstract] [Full Text] [Related]
5. Targeting NOX enzymes in the central nervous system: therapeutic opportunities.
Sorce S; Krause KH; Jaquet V
Cell Mol Life Sci; 2012 Jul; 69(14):2387-407. PubMed ID: 22643836
[TBL] [Abstract][Full Text] [Related]
6. Nicotinamide adenine dinucleotide phosphate oxidase in experimental liver fibrosis: GKT137831 as a novel potential therapeutic agent.
Aoyama T; Paik YH; Watanabe S; Laleu B; Gaggini F; Fioraso-Cartier L; Molango S; Heitz F; Merlot C; Szyndralewiez C; Page P; Brenner DA
Hepatology; 2012 Dec; 56(6):2316-27. PubMed ID: 22806357
[TBL] [Abstract][Full Text] [Related]
7. Molecular insights of NADPH oxidases and its pathological consequences.
Waghela BN; Vaidya FU; Agrawal Y; Santra MK; Mishra V; Pathak C
Cell Biochem Funct; 2021 Mar; 39(2):218-234. PubMed ID: 32975319
[TBL] [Abstract][Full Text] [Related]
8. Inhibiting the Activity of NADPH Oxidase in Cancer.
Konaté MM; Antony S; Doroshow JH
Antioxid Redox Signal; 2020 Aug; 33(6):435-454. PubMed ID: 32008376
[No Abstract] [Full Text] [Related]
9. NADPH oxidase enzymes in skin fibrosis: molecular targets and therapeutic agents.
Babalola O; Mamalis A; Lev-Tov H; Jagdeo J
Arch Dermatol Res; 2014 May; 306(4):313-330. PubMed ID: 24155025
[TBL] [Abstract][Full Text] [Related]
10. NADPH Oxidase Inhibition in Fibrotic Pathologies.
Bernard K; Thannickal VJ
Antioxid Redox Signal; 2020 Aug; 33(6):455-479. PubMed ID: 32129665
[No Abstract] [Full Text] [Related]
11. Evolution of NADPH Oxidase Inhibitors: Selectivity and Mechanisms for Target Engagement.
Altenhöfer S; Radermacher KA; Kleikers PW; Wingler K; Schmidt HH
Antioxid Redox Signal; 2015 Aug; 23(5):406-27. PubMed ID: 24383718
[TBL] [Abstract][Full Text] [Related]
12. NOX enzymes as drug targets.
Krause KH; Lambeth D; Krönke M
Cell Mol Life Sci; 2012 Jul; 69(14):2279-82. PubMed ID: 22585058
[No Abstract] [Full Text] [Related]
13. NADPH oxidase-mediated induction of reactive oxygen species and extracellular matrix deposition by insulin-like growth factor binding protein-5.
Yasuoka H; Garrett SM; Nguyen XX; Artlett CM; Feghali-Bostwick CA
Am J Physiol Lung Cell Mol Physiol; 2019 Apr; 316(4):L644-L655. PubMed ID: 30810066
[TBL] [Abstract][Full Text] [Related]
14. Targeting NADPH oxidases in vascular pharmacology.
Schramm A; Matusik P; Osmenda G; Guzik TJ
Vascul Pharmacol; 2012; 56(5-6):216-31. PubMed ID: 22405985
[TBL] [Abstract][Full Text] [Related]
15. [Research progress of NADPH oxidases and their inhibitors].
Yang XL; Chen YJ; Hu GY; Li QB
Yao Xue Xue Bao; 2016 Apr; 51(4):499-506. PubMed ID: 29859517
[TBL] [Abstract][Full Text] [Related]
16. The NADPH Oxidase Family and Its Inhibitors.
Chocry M; Leloup L
Antioxid Redox Signal; 2020 Aug; 33(5):332-353. PubMed ID: 31826639
[No Abstract] [Full Text] [Related]
17. Glucose-6-Phosphate Dehydrogenase Deficiency Activates Endothelial Cell and Leukocyte Adhesion Mediated via the TGFβ/NADPH Oxidases/ROS Signaling Pathway.
Parsanathan R; Jain SK
Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33050491
[TBL] [Abstract][Full Text] [Related]
18. NADPH Oxidase Inhibition: Preclinical and Clinical Studies in Diabetic Complications.
Urner S; Ho F; Jha JC; Ziegler D; Jandeleit-Dahm K
Antioxid Redox Signal; 2020 Aug; 33(6):415-434. PubMed ID: 32008354
[No Abstract] [Full Text] [Related]
19. Serotonin Signaling Through the 5-HT
Hood KY; Mair KM; Harvey AP; Montezano AC; Touyz RM; MacLean MR
Arterioscler Thromb Vasc Biol; 2017 Jul; 37(7):1361-1370. PubMed ID: 28473438
[TBL] [Abstract][Full Text] [Related]
20. NADPH oxidases and oxidase crosstalk in cardiovascular diseases: novel therapeutic targets.
Zhang Y; Murugesan P; Huang K; Cai H
Nat Rev Cardiol; 2020 Mar; 17(3):170-194. PubMed ID: 31591535
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
